Posted on November 24, 2010 by Albin Paul
Vicki Phelan, Managing Director, Pharmaceutical and Life Sciences Practice with Stan Lepeak, Managing Director, Global Research Trends in the life sciences and pharma research and development outsourcing (RDO) The complete report is available at http://goo.gl/MgVBu
Filed under: clinical research, Clinical Trial | Tagged: clinical research, clinical research organizatio, Clinical Trial, CRO, Drug Development, drug discovery, outsourcing | 1 Comment »
Posted on November 24, 2010 by Albin Paul
Oracle Siebel CRM is the base application behind Oracle’s Siebel CTMS. Prepackaged OBIEE Applications does not have a module for Clinical Analytics and so there is a need to develop a complete custom OBI application in order to accomplish the requirements. This was untill Oracle has introduced Oracle Clinical Development Analytics (CDA) which is based on [...]
Filed under: clinical informatics, clinical research, Clinical Trial, oracle | Tagged: Business Intelligence, Clinical Trials Management System, CTMS, oracle, Oracle Business Intelligence, oracle heatlh sciences global business unit, Siebel CRM | Leave a Comment »
Posted on November 24, 2010 by Albin Paul
one of the very few interesting article by Microsoft Engineers on Clinical Research Industry. Certainly interesting as it is written by none other than Les Jordan-CTO, Life Sciences Industry Unit at Microsoft . Microsoft and IBM had much longer and deepr association with Lifescience/Healthcare/Bioinformatics industry than Oracle. But I love to see microsoft [...]
Filed under: clinical research, clinical software, Clinical Trial | Tagged: clinical research, Clinical Trial, clinical trials management software, Clinical Trials Management System, CTMS, EDC, microsoft, oracle | 1 Comment »
Posted on November 24, 2010 by Albin Paul
I had posted last month about the Pegasystem pharmacovigilance solution. Pega Systems the industry leader in Business Process Management (BPM) software solutions, released a Pharmacovigilance case processing software. Pega has experience in clinical trial space, specifically in Clinical Trial Management. The solution is designed for rapid deployment to quickly leverage existing adverse event processing rules and requirements and can [...]
Filed under: Drug Safety, pharmacovigilance | Tagged: clinical research, Clinical Trial, pharmacovigilance | Leave a Comment »
Posted on November 24, 2010 by Albin Paul
Laboratory Corporation of America Holdings…announced…a collaboration between Esoterix Clinical Trials Services, a division of LabCorp, and Clearstone Central Laboratories, a global central laboratory specializing in drug development and pharmaceutical services.…The collaboration provides LabCorp with access to Clearstone’s global network of labs, including China, France, Singapore and Canada, in addition to LabCorp’s existing labs in the [...]
Filed under: clinical informatics, clinical software | Tagged: clinical trials management software, clinical trials management sysem, CTMS | 2 Comments »
Posted on November 23, 2010 by Albin Paul
The multinational pharma companies are planning to approach the health ministry with a proposal calling for the utilisation of the 1.7 lakh post offices across the country to distribute over the counter drugs. The move if implemented would increase the reach of OTC drugs by 20%. The plan initially submiited 2 years ago requires the approval [...]
Filed under: Drug Safety, pharmacovigilance | Leave a Comment »
Posted on November 23, 2010 by Albin Paul
Scott Stern, Associate Professor, Kellogg School of Management, speaks on the topic of, “New Drug Development: From Laboratory to Blockbuster to Generic,” at the Judicial Symposium on The Pharmaceutical Industry: Economics, Regulation, and Legal Issues, hosted by the Northwestern Law Judicial Education Program
Filed under: clinical research, Clinical Trial, drug development, drug discoverry | Tagged: Drug Development, drug discovey | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
There have been several cases where Fraud in clinical trial has questioned the Integrity of Data and ethics , when conducting clinical trial in India, which have been used by crusaders against outsourcing. But the new evidence suggest that the clinical trial fraud is more prevalent even in US. The most recent being MannKind Corporation Accused [...]
Filed under: microarray | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | 4 Comments »
Posted on November 18, 2010 by Albin Paul
Had an interesting chat with the CEO of the US based IT service provider for clinical research industry in June. Apparently the company a SalesForce.com partner introduces new CTMS application in India. Just came to know that they are going commercial this month. The applications is aimed at clinical trial management, Study site management and Patient Recruitment [...]
Filed under: clinical research, clinical software, Clinical Trial, cloud computing, SaaS | Tagged: clinical trial management software, Clinical Trial Management System, Clinical Trials Management System, cloud computing, CRM, CTMS, force platform, SaaS, salesforce.com | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
Implementation of a computer-automated safety surveillance system of clinical outcomes registries for cardiovascular devices resulted in the identification of a drug-releasing stent that had significantly higher rates of major adverse cardiac events than similar stents “Monitoring the safety of approved medical products is of vital public health importance, given that in clinical practice such medical [...]
Filed under: Drug Safety, Patient Safety, pharmacovigilance | Tagged: Drug Safety, medical device safety, patient safety, pharmacovigilance, post market surveillance | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
According to a British Medical Journal, article on the effectiveness of post-market surveillance, medical device manufacturers “often fail to properly conduct safety studies” and the Food and Drug Administration (FDA) “provides scant oversight” in post-approval monitoring of these devices. The article is published by Jeanne Lenzer and Shannon Brownlee, called “Why the FDA can’t protect [...]
Filed under: Drug Safety, pharmacovigilance | Tagged: Drug Safety, FDA, pharmacovigilance, post market surveillance | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
Canada’s Food and Drugs Act relies on drug companies to submit adverse reaction reports, which drug users submit if they suspect they are experiencing negative side effects. Drug users also can submit the reports directly to Health Canada, but it still leaves the government to rely on outside parties to report problems. In 2009, Health [...]
Filed under: clinical research, drug development, drug discoverry, Drug Safety, pharmacovigilance | Tagged: clinical research, Drug Safety, pharmacovigilance, post market surveillance | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
Industry Standard Research (ISR) today announced the launch of a new and substantial research report titled “The Voice of the Site Coordinator.” This report presents data and analysis from 124 interviews with Study / Site Coordinators from the US, Europe, Latin America, and Asia. Kevin Olson, CEO, Industry Standard Research. Olson says “Our data suggest that [...]
Filed under: clinical software, Clinical Trial | Leave a Comment »
Posted on November 18, 2010 by Albin Paul
The Department of Science and Technology (DST) will set up enhanced clinical research units in select colleges across India , Delivering the valedictory address at the International Conference on Radiation Biology hosted by Sri Ramachandra University, DST Secretary T. Ramasami said the idea behind the joint inter-agency initiative that also involved the Indian Council of [...]
Filed under: clinical research, Clinical Trial, outsourcing | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
China’s health and medical industry is advancing rapdily within genomics, combinatorial chemistry and high-throughput screening, China has been recognised as an important location to which drug discovery is being outsourced. The Chinese drug discovery market reached US$315.0 million in 2009 and is predicted to expand at a compound annual growth rate of 23% from 2009 to [...]
Filed under: clinical research, Clinical Trial, drug development, Drug Discovery | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
Eli Lilly’s CIO Michael Heim says that the drug giant’s right to know where in the cloud its data resides, and to know the provider’s disaster recovery plans are chief issues that will drive the use of cloud computing in clinical data within drug discovery and development projects. An interview with Michael Heim is available [...]
Filed under: drug development, drug discoverry, Drug Discovery | Tagged: clinical data, cloud computing, Drug Development, drug discovery | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
The top 10 pharmaceutical companies out of the world’s top 50 have lower estimated overall clinical approval success rates than do smaller firms in that group, but nonetheless appeared to have some R&D productivity advantages, according to a new study completed by the Tufts Center for the Study of Drug Development. Despite experiencing lower overall [...]
Filed under: drug development | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
According to a new report from the Tufts Center for the Study of Drug Development at Tufts University 12 to 50 percent of the drugs companies are developing, depending on the company, involved a personalized medicine approach. The Tufts report is based on a survey of 25 companies, large and small, to which 16 companies [...]
Filed under: clinical research, Clinical Trial, drug development, drug discoverry, personalized medicine, Pharmacogenomics, Theranostics | Tagged: Drug Development, drug discovery, personalized medicine, theranostics | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
George Whitesides, a Harvard chemistry professor has designed technology in which patients’ blood is dropped on a piece of paper, and water-repellent ink resembling that of a comic book creates diagnostic colors on the other side, CNN reports. The technology may be incorporated into mobile phones, according to CNN. Whitesides’ prototype allows for testing of [...]
Filed under: personalized medicine, Theranostics | Tagged: clinical research, Clinical Trial, Drug Development, drug discovery | Leave a Comment »
Posted on November 17, 2010 by Albin Paul
UK’s Medical Research Council grants a Clinical Research consortium $6.4 million to develop chips & software to use mobile phones/PCs as testing devices for sexually transmitted disease (STD) If successful individuals will drop their blood, urine or saliva on a mobile chip, which they then insert into a mobile phone or PC. Software on the [...]
Filed under: clinical research, clinical software, Clinical Trial, personalized medicine, Theranostics | Tagged: clinical research, Clinical Trial, Drug Development | 1 Comment »